GlassScriptPhysician profile
Margaret M Bast
NPI 1124407457
$2,289.27
in general payments reported to CMS, 2019-2025
29 companies · $117 in 2025
The $117 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $427 · 2022: $424 · 2023: $867 · 2024: $454 · 2025: $117.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,438.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,437.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $241.94 | 2023-2024 | Barostim Neo System |
| E.R. Squibb & Sons, L.L.C. | $217.49 | 2021-2024 | Camzyos, Eliquis |
| Amgen INC. | $205.32 | 2021-2024 | Repatha |
| Medtronic, INC. | $189.11 | 2021-2024 | Venaseal |
| Astrazeneca Pharmaceuticals LP | $151.63 | 2021-2024 | Farxiga, Lokelma |
| Philips North America LLC | $120.65 | 2023-2025 | Ambulatory Monitoring & Diagnostics Undivided, (5091) Amb Mon & Diag Und |
| Heartflow, INC. | $101.22 | 2022 | |
| Merck Sharp & Dohme LLC | $97.33 | 2021-2024 | Verquvo |
| Janssen Pharmaceuticals, INC | $89.61 | 2021-2022 | |
| Veryan Medical Incorporated | $86.53 | 2023-2024 | Biomimics 3d Vascular Stent System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $86.31 | 2023-2025 | Lifevest |
| Kiniksa Pharmaceuticals, LTD. | $85.59 | 2021-2023 | Arcalyst |
| Esperion Therapeutics, INC. | $76.32 | 2021-2023 | Nexletol |
| Pfizer INC. | $72.55 | 2021-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $66.39 | 2022-2023 | Jardiance |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kiniksa Pharmaceuticals International, Plc | $66.36 | 2024 | Arcalyst |
| Kestra Medical Technology Services, INC. | $35.60 | 2023 | Assure Wcd |
| Lexicon Pharmaceuticals, INC. | $34.27 | 2024 | |
| Tactile Systems Technology INC | $31.96 | 2022-2023 | Entre Plus, Flexitouch Plus |
| Sanofi-Aventis U.S. LLC | $30.62 | 2023-2024 | |
| Cardiva Medical, INC. | $29.69 | 2022 | |
| Abbott Laboratories | $29.03 | 2023 | Ensite Precision |
| Abiomed | $28.74 | 2023 | Impella |
| Impulse Dynamics (USA) INC. | $25.63 | 2022 | |
| Baxter Healthcare | $24.31 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Novartis Pharmaceuticals Corporation | $18.61 | 2022 | |
| Bardy Diagnostics, INC. | $16.65 | 2021 | |
| Boston Scientific Corporation | $16.56 | 2024 | Angiojet Ultra 5000a |
| Kowa Pharmaceuticals America, INC. | $13.25 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Margaret Bast listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.